$ONC Cashflow Statement | Understand Stock

$ONC

$370.87 -$6.76 (1.79%) Close

$ONC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expense
Share-based compensation expense
Acquired in-process research and development
Amortization of research and development cost share liability
Unrealized losses on long-term investments
Impairment of equity investments
Loss on long-term investments
Non-cash interest expense
Deferred income tax expense
Gain on BMS termination settlement
Other items, net
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Other assets
Accounts payable
Accrued expenses and other payables
Deferred revenue
Other liabilities
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of short-term investments
Purchase of in-process research and development
Purchase of intangible assets
Purchase of long-term investments
Proceeds from sale or maturity of short-term investments
Other investing activities
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Proceeds from public offering, net of cost
Proceeds from sale of ordinary shares, net of cost
Proceeds from research and development cost share liability
Payment to acquire joint venture (JV) minority interest
Proceeds from sale of future royalties
Proceeds from long-term loan
Repayment of long-term loan
Proceeds from short-term loans
Repayment of short-term loans
Capital contribution from noncontrolling interest
Payments of debt issuance costs
Payments of withholding taxes from share-based awards
Proceeds from option exercises and employee share purchase plan
Repayment of sale of future royalties liability
Other financing activities
Net cash provided by financing activities

Effect of foreign exchange rate changes, net
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of year
Cash, cash equivalents, and restricted cash, end of year
Supplemental cash flow disclosures:
Cash and cash equivalents
Short-term restricted cash
Long-term restricted cash
Income taxes paid
Interest paid
Supplemental non-cash activities:
Accruals for capital expenditures
Purchase of in-process research and development included in accounts payable

Comments